LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER
|
Back to Search Results |
|
Model Number 9010 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hemorrhage/Bleeding (1888); Restenosis (4576)
|
Event Date 10/18/2022 |
Event Type
Injury
|
Event Description
|
It was reported through results of clinical trial that three months and eighteen days post index procedure using drug-coated balloon catheter, subject had adverse event stenosis which required additional surgical intervention.It was further reported that five months seven days post index procedure, patient reportedly experienced restenosis.The target lesion had initial stenosis of ninety percent.Treatment re-intervention was successful, and the patient recovered with residual stenosis of five percent.However, the current status of the patient is unknown.
|
|
Manufacturer Narrative
|
As the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Expiry date: 02/2023.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: b5, d4 (expiry date: 02/2023), g3, h6 (method) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
|
|
Event Description
|
It was reported through results of clinical trial that three months and eighteen days post index procedure using drug-coated balloon catheter, subject had adverse event stenosis of cephalic arch vein which required additional surgical intervention.It was further reported that five months seven days post index procedure, subject had adverse event stenosis of cephalic arch vein which required additional surgical intervention.Reportedly, the patient experienced restenosis.The target lesion had initial maximum stenosis of ninety percent.Treatment re-intervention was successful, and the patient recovered with final residual stenosis of five percent.However, the current status of the patient is unknown.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiry date: 02/2023), g3, h6 (patient).H11: b5.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported through the results of clinical trial that three months and eighteen days post index procedure using drug-coated balloon catheter in cephalic vein, subject had an adverse event stenosis of cephalic arch vein which required an arteriovenous access circuit reintervention.It was further reported that five months and seven days post index procedure, subject had an adverse event stenosis of cephalic arch vein which required an arteriovenous access circuit reintervention.It was also reported that eight months and seven days post index procedure, subject had an adverse event malfunctioning fistula due to elevated venous pressures which required an arteriovenous access circuit reintervention.Furthermore, one year and twenty days post index procedure, subject developed an adverse event malfunctioning fistula due to prolonged bleeding which required an arteriovenous access circuit reintervention.Reportedly, the patient experienced target lesion restenosis and prolonged bleeding.Standard percutaneous transluminal angioplasty was used for treatment.The re-intervention was successful, and no new access was created.The current status of the patient is unknown.
|
|
Search Alerts/Recalls
|
|
|